MYC and lymphoma: 2.2. MYC Downregulation by Synthetic MYC Inhibitor 10058-F4 Sensitizes Lymphoma Cells Towards Daratumumab-Mediated and T Cell-Redirected Cytotoxicity Independent of Target Antigen Expression